López Díaz, María CarmenCulebras López, EstherRodríguez-Avial Infante, IciarRíos Dueñas, EstherViñuela Prieto, José ManuelPicazo De La Garza, Juan JoséRodríguez-Avial López-Doriga, Carmen2024-12-172024-12-172016-12-05López-Diaz MDC, Culebras E, Rodríguez-Avial I, Rios E, Viñuela-Prieto JM, Picazo JJ, Rodríguez-Avial C. 2017. Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes. Antimicrob Agents Chemother 61:10.1128/aac.02454-16. https://doi.org/10.1128/aac.02454-160066-480410.1128/AAC.02454-16https://hdl.handle.net/20.500.14352/112723National R&D Plan, AES 2013The activity of plazomicin and clinically relevant aminoglycosides was tested against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates, and the results were correlated with the presence of aminoglycoside-modifying enzymes (AMEs). Data showed that plazomicin was very active against all ESBL/AmpC-producing E. coli urinary isolates. Its activity was not related to the AME genes studied.spajournal article1098-6596https://doi.org/10.1128/aac.02454-16https://journals.asm.org/doi/10.1128/aac.02454-16restricted access579.61AMEsESBLEscherichia coliplazomicinaminoglycosidesCiencias Biomédicas3201.03 Microbiología Clínica